Treosulfan‐based reduced toxicity hematopoietic stem cell transplantation in X‐linked agammaglobulinemia: A cost‐effective alternative to long‐term immunoglobulin replacement in developing countries-Reference-Cited by-同舟云学术

Treosulfan‐based reduced toxicity hematopoietic stem cell transplantation in X‐linked agammaglobulinemia: A cost‐effective alternative to long‐term immunoglobulin replacement in developing countries

Published:2019-12-10 Issue:1 Volume:24 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Vellaichamy Swaminathan Venkateswaran¹,Uppuluri Ramya¹^ORCID,Patel Shivani¹,Melarcode Ramanan Kesavan¹,Ravichandran Nikila¹,Jayakumar Indira²,Vaidhyanathan Lakshman³,Raj Revathi¹

Affiliation:

1. Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation Apollo Hospitals Chennai India

2. Department of Pediatric Critical Care Apollo Hospitals Chennai India

3. Department of Stem Cell Pheresis Apollo Hospitals Chennai India

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13625

Reference13 articles.

1. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies